12 Jun 2018 16:00
BIOPHARMA CREDIT PLC
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
1. | Details of person discharging managerial responsibilities/person closely associated with them | ||||||||||||||
a) | Name | Anita Hyman | |||||||||||||
2. | Reason for the notification | ||||||||||||||
a) | Position / status | Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC) | |||||||||||||
b) | Initial notification / amendment | Initial notification | |||||||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||||||
a) | Name | BioPharma Credit PLC | |||||||||||||
b) | LEI | 213800AV55PYXAS7SY24 | |||||||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||
a) | Description of the financial instrument
Identification Code | Ordinary Shares of $0.01 each
GB00BDGKMY29 | |||||||||||||
b) | Nature of the transaction | Purchase of Shares (acquired as part of dividend reinvestment) | |||||||||||||
c) | Price(s) and volume(s) |
| |||||||||||||
d) | Aggregated information - Aggregated volume
- Price | N/A
| |||||||||||||
e) | Date of the transaction | 1. 20.11.17 2. 18.02.18 3. 16.04.18 | |||||||||||||
f) | Place of the transaction | London Stock Exchange (XLON) | |||||||||||||